Global Venous Diseases Treatment Market, By Product Type (Sclerotherapy Injection, Ablation Devices, Venous Closure Products, Venous Stents, Medication and Others), Disease Type (Deep Vein Thrombosis (DVT), Chronic Venous Insufficiency (CVI), Pulmonary Embolism, Superficial Thrombophlebitis, Varicose Veins, and Others), Treatment Type (Sclerotherapy, Radiofrequency ablation therapy, Laser Treatment, Ambulatory Phlebectomy, Vein Ligation and stripping, Angioplasty or Stenting, Surgeries, Compression Therapy, Venoactive Medication, Vena Cava Filter and Others Therapies), End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) - Industry Trends and Forecast to 2030.
Venous Diseases Treatment Market Analysis and Insights
Venous disease includes blood clots in the legs, arms, brain, lungs or internal organs such as kidney, spleen, liver, deep vein thrombosis, chronic venous insufficiency, varicose veins, and veins, and ulcers in the veins. Treatment for this disease includes drug therapy, endogenous laser ablation or radiofrequency ablation (RFA), sclerotherapy, and surgery.
Data Bridge Market Research analyzes that the global venous diseases treatment market is expected to reach the value of USD 10,117.88 million by 2030, at a CAGR of 7.3% during the forecast period. This market report also covers pricing analysis, patent analysis, and technological advancements in depth.
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2020-2015)
|
|
Quantitative Units
|
Revenue in Million, Pricing in USD
|
|
Segments Covered
|
By Product Type (Sclerotherapy Injection, Ablation Devices, Venous Closure Products, Venous Stents, Medication and Others), Disease Type (Deep Vein Thrombosis (DVT), Chronic Venous Insufficiency (CVI), Pulmonary Embolism, Superficial Thrombophlebitis, Varicose Veins, and Others), Treatment Type (Sclerotherapy, Radiofrequency ablation therapy, Laser Treatment, Ambulatory Phlebectomy, Vein Ligation and stripping, Angioplasty or Stenting, Surgeries, Compression Therapy, Venoactive Medication, Vena Cava Filter and Others Therapies), End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, Russia, Italy, U.K., Spain, Turkey, Netherlands, Belgium, Switzerland, Israel, and Rest of Europe, China, India, Japan, Indonesia, Philippines, Thailand, Australia, Malaysia, South Korea, Singapore, Rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, and Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America
|
|
Market Players Covered
|
Abbott, Imricor, Baylis Medical Company, Inc., Theraclion, Sonablate, plusmedica.de, Boston Scientific Corporation, Olympus Corporation, Smith + Nephew, Cook, Scitech, Carl Zeiss Meditec AG, Teleflex incorporated, Alma Lasers, BD, B.Braun SE, Medtronic, Stryker, Koninklijke Philips N.V., Varian Medical Systems, Candela Corporation, Teromo corporation, Angiodynamics, optimed Medizinische Instrumente GmbH, Merit Medical Systems and Bolitec Laser among others.
|
Global Venous Diseases Treatment Market Definition
Heart attacks, and strokes are usually acute events, and are primarily caused by a blockage that blocks blood flow to the heart or brain. The most common cause is the build-up of fatty deposits in the lining of the blood vessels that supply the heart or brain. A stroke can be caused by bleeding or blood clots in a blood vessel in the brain.
Technological advancements in vascular stents, increase in demand for minimally invasive procedures, and rise in geriatric population are driving the global market. Moreover, the companies are expanding their product portfolio to offer the best services for venous diseases treatment. Medical devices such as ablation devices are used in minimally invasive procedures to remove or excise abnormal body tissues for therapeutic purposes. These systems use the heat generated by radio frequency, energy, extreme cold, or a laser to cause small burns. Rise in adoption of robotic technologies for product application expansion, and integration of cutting-edge technologies in ablation devices to improve patient safety, and procedural efficiency are expected to drive the market.
Global Venous Diseases Treatment Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Rising incidences of venous diseases
Venous diseases are the conditions that damage veins in body. Damaged blood vessel walls prevent the circulatory system from working, causing blood to pool and reflux (backwards) when the muscles relax. This causes abnormally high pressure to build up in the veins. This build-up causes veins to tighten and twist, increased swelling, increased valve incompetence, slow blood flow, and possible blood clots. Finally, this condition can lead to various diseases known as venous diseases.
Due to various risk factors such as ageing, obesity, high blood pressure (hypertension) or family history of venous disease, patients with venous diseases are rising globally and becoming a significant socio-economic issue. Thus the rising number of patients with venous diseases increases the demand for venous diseases treatment which act as a driver in the global venous diseases treatment market.
- Rapid changes in lifestyle leads to obesity resulting in venous diseases
Lifestyle changes such as smoking, unhealthy diet and physical inactivity lead to the development of chronic diseases, especially heart disease, stroke, diabetes, obesity and metabolic syndrome that can eventually result in venous diseases.
Physical activity is essential and many conditions are a direct result of a sedentary lifestyle. Sedentary lifestyle may result in gain weight, tire easily and have unexplained aches and pains that develop chronic condition, including cardiovascular and venous disease, ranging from moderate, severe or even life-threatening.
According to the article of ScienceDirect, venous disease was more clinically severe in the obese limbs than non-obese group. Thus due to increase in adoption of unhealthy lifestyle there is rapid increase in obese population with venous diseases rising. Thus the rapid changes in lifestyle leads to obesity resulting in venous diseases which increases the demand for venous diseases treatment and act as a driver in the global venous diseases treatment market.
Restraint
- Lack of skilled and certified professionals
The requirement of skilled and certified professionals is a big restraint for venous diseases treatment market. The demand for venous disease treatment is increased due to increasing cases of venous diseases in the Europe but the less number of skilled professionals present in the healthcare center is hampering the growth of the market.
Chronic venous disease (CVD) is often overlooked by healthcare professionals because they do not understand the extent and impact of the problem, and the different manifestations of primary and secondary venous disease are not fully recognized. The importance of cardiovascular diseases is related to the number of patients and to the socio-economic effects of its more serious manifestations.
Opportunity
- Rising awareness towards venous disorders
Both medicinal procedures and lifestyle changes can be used to treat vein problems. Your veins can benefit from medication, exercise, and compression stockings, but occasionally vein problems necessitate more thorough therapy to restore the health and performance of your veins. The course of treatment is determined by the kind and severity of the venous disease. Patients with vascular disorders have increased dramatically over the past few decades, with diabetes serving as the most flagrant risk factor. Unlike other health problems, vascular disorders and vascular surgery are unknown to approximately 80% of the population. People's attitudes and behaviours about particular illnesses can change significantly as a result of increased health awareness.
There are several awareness programs are conducted by various societies, government institutes and others. These initiatives taken by them will increase awareness among people regarding their health and take early diagnosis for better cure and precaution. For this reason, rising awareness towards venous disorders are expected to act as an opportunity for growing the demand of the global venous diseases treatment market.
Challenge
- High cost associated with venous disease treatment
More than 25 million persons in the United States alone suffer from chronic venous insufficiency (CVI), with more than 6 million having advanced venous illness. The US healthcare system is heavily burdened financially as a result of the high incidence of CVI and rising healthcare costs. Numerous widespread health issues are caused by poor venous circulation. Leg pain, edoema, and heaviness are some of the early signs of chronic venous disease (CVD), and they can be present all day long or become more pronounced in the evening. Patients frequently seek out initial therapy for symptoms that might occur with or without varicose veins, as well as for cosmetic varicose vein removal. The two main risk factors for CVD are advancing age and high body mass.
Post-COVID-19 Impact on Global Venous Diseases Treatment Market
The pandemic has had adverse impacts on the manufacturers as well as users. As varicose veins procedures are non-urgent, the volume of procedures declined drastically. Reduction in the surgeries or procedures for the treatment of varicose veins due to traveling restrictions also impacted the sales of the manufacturers.
Manufacturers are making various strategic decisions to bounce back post-COVID-19. The players are conducting multiple R&D activities and product launch and strategic partnerships to improve the technology and test results involved in the pet food flavors and ingredients market.
Recent Developments
- In July 2022, Smith+Nephew, the global medical technology company has launches Clinical Support App to help reduce practice variation in wound care. The WOUND COMPASS Clinical Support App is a comprehensive digital support tool for health care professionals that aids wound assessment and decision-making to help reduce practice variation. This has helped the company to attract the healthcare customers and expand product portfolio
- In April 2022, Carl Zeiss Meditec has announced the acquisition of two manufacturers of surgical instruments (Kogent Surgical, LLC and Katalyst Surgical, LLC) to further strengthen its positioning as a solution provider. This has helped the company to expand their business
Global Venous Diseases Treatment Market Scope
Global venous diseases treatment market is segmented into product type, disease type, treatment type, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
GLOBAL VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE
- ABLATION DEVICES
- VENOUS STENTS
- VENOUS CLOSURE PRODUCTS
- SCLEROTHERAPY INJECTION
- MEDICATIONS
- OTHERS
On the basis of product type, the global venous diseases treatment market is segmented into ablation devices, venous stents, venous closure products, sclerotherapy injection, medications, and others
GLOBAL VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE
- DEEP VEIN THROMBOSIS (DVT)
- CHRONIC VENOUS INSUFFICIENCY (CVI)
- PULMONARY EMBOLISM
- SUPERFICIAL THROMBOPHLEBITIS
- VARICOSE VEINS
- OTHERS
On the basis of disease type, the global venous diseases treatment market is segmented into deep vein thrombosis (DVT), chronic venous insufficiency (CVI), pulmonary embolism, superficial thrombophlebitis, varicose veins, and others
GLOBAL VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE
- COMPRESSION THERAPY
- VENO ACTIVE MEDICATION
- SURGERIES
- SCLEROTHERAPY
- ANGIOPLASTY OR STENTING
- VEIN LIGATION AND STRIPPING
- VENA CAVA FILTER
- AMBULATORY PHLEBECTOMY
- RADIOFREQUENCY ABLATION THERAPY
- LASER TREATMENT
- OTHERS THERAPIES
On the basis of treatment type, the global venous diseases treatment market is segmented into compression therapy, veno active medication, surgeries, scelrotherapy, angioplasty or stenting, vein legation, and stripping, vena cava filter, ambulatory phlebectomy, radiofrequency ablation therapy, laser treatment, and other therapies
GLOBAL VENOUS DISEASES TREATMENT MARKET, BY END USER
- HOSPITALS
- CLINICS
- AMBULATORY SURGICAL CENTERS
- OTHERS
On the basis of end user, the global venous diseases treatment market is segmented into hospitals, clinics, ambulatory surgical centers, and others
GLOBAL VENOUS DISEASES TREATMENTS MARKET, BY DISTRIBUTION CHANNEL
- DIRECT TENDER
- RETAIL SALES
- OTHERS
On the basis of distribution channel, the global venous diseases treatment market is segmented into direct tender, retail sales, and others
Global Venous Diseases Treatment Market Regional Analysis/Insights
The global venous diseases treatment market is analyzed and market size information is provided product type, disease type, treatment type, end user, and distribution channel.
Global venous diseases treatment market comprises of the countries U.S., Canada, Mexico, Germany, France, Russia, Italy, U.K., Spain, Turkey, Netherlands, Belgium, Switzerland, Israel, and Rest of Europe, China, India, Japan, Indonesia, Philippines, Thailand, Australia, Malaysia, South Korea, Singapore, Rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, and Rest of Middle East, and Africa, Brazil, Argentina, and Rest of South America.
North America is dominating due to the presence of key market players in the largest consumer market with high GDP.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Venous Diseases Treatment Market Share Analysis
Global venous diseases treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus on the global venous diseases treatment market.
Some of the major players operating in the global venous diseases treatment market are Abbott, Imricor, Baylis Medical Company, Inc., Theraclion, Sonablate, plusmedica.de, Boston Scientific Corporation, Olympus Corporation, Smith + Nephew, Cook, Scitech, Carl Zeiss Meditec AG, Teleflex incorporated, Alma Lasers, BD, B.Braun SE, Medtronic, Stryker, Koninklijke Philips N.V., Varian Medical Systems, Candela Corporation, Teromo corporation, Angiodynamics, optimed Medizinische Instrumente GmbH, Merit Medical Systems, Bolitec Laser among others.
SKU-